Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Ty21a
BIOLOGICAL
2 trials
Sponsors
University of Oxford
, Patrice Jichlinski
Conditions
Enteric Fever
Non Muscle Invasive Bladder Cancer
Typhoid
Typhoid Fever
Phase 1
Intravesical Ty21a for the Treatment of Patients With Non-muscle-invasive Bladder Cancer (NMIBC)
NCT03421236
Patrice Jichlinski
Non Muscle Invasive Bladder Cancer
Start: 2018-02-18
End: 2022-12-01
Target: 25
Updated: 2021-04-28
Phase 2
Understanding Typhoid Disease After Vaccination
Completed
NCT01405521
University of Oxford
Enteric Fever, Typhoid, Typhoid Fever
Start: 2011-10-07
End: 2022-05-06
Updated: 2023-05-06
Related Papers
Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential
Journal for ImmunoTherapy of Cancer
2023-12-01
5 citations
Intravesical Ty21a Treatment of Non-muscle-invasive Bladder Cancer Shows a Good Safety Profile.
2022-10-03
5 citations
Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a
PLoS neglected tropical diseases
2016-08-17
80 citations